Certoparin
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Certoparin is a low molecular weight heparin (LMWH) used to prevent blood clots, specifically deep vein thrombosis.
- Generic Name
- Certoparin
- DrugBank Accession Number
- DB09261
- Background
Certoparin is part of the heparins of low molecular weight that presents high activity against the coagulation factor Xa. It is normally used to prevent deep venous thrombosis.
- Type
- Small Molecule
- Groups
- Approved, Investigational
- Synonyms
- Not Available
Pharmacology
- Indication
Used in the prevention and treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism) and in the treatment of myocardial infarction.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Prevention of Deep vein thrombosis •••••••••••• •••••••• •••• ••••••••• Prevention of Deep vein thrombosis •••••••••••• •••• •••• ••••••••• Prevention of Thrombotic events caused by general surgery •••••••••••• ••••••••••••• ••••••••• Prevention of Thrombotic events caused by general surgery •••••••••••• ••••••••••••• ••••••••• Prevention of Thrombotic events caused by mobility decreased •••••••••••• •••• •••• ••••••••• - Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAcebutolol The risk or severity of hyperkalemia can be increased when Acebutolol is combined with Certoparin. Aceclofenac The risk or severity of hyperkalemia can be increased when Aceclofenac is combined with Certoparin. Acemetacin The risk or severity of hyperkalemia can be increased when Certoparin is combined with Acemetacin. Acetylsalicylic acid The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Certoparin. Alclofenac The risk or severity of hyperkalemia can be increased when Certoparin is combined with Alclofenac. - Food Interactions
- Avoid herbs and supplements with anticoagulant/antiplatelet activity. Examples include garlic, ginger, bilberry, danshen, piracetam, and ginkgo biloba.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- International/Other Brands
- Embolex / Sandoparin
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- V72OT3K19I
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
- PubChem Substance
- 347910425
- 152610
- Wikipedia
- Certoparin_sodium
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Unknown Status Treatment Heparin Induced Thrombocytopenia (HIT) 1 3 Completed Prevention Renal Dialysis 1 3 Completed Prevention Systemic Embolism 1 3 Completed Prevention Thromboembolism 1 3 Completed Treatment Persistent Nonvalvular Atrial Fibrillation 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Parenteral 3000 IE Injection, solution Parenteral 8000 IE - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at October 26, 2015 17:10 / Updated at May 07, 2021 21:06